Dr. Canter's clinical interests include soft tissue sarcoma, upper gastrointestinal (GI) malignancies including stomach, pancreas, and hepatobiliary. His research interests includes soft tissue sarcoma, radiologic and metabolic markers of response to neoadjuvant therapy, as well as novel treatment strategies for neoadjuvant therapy.
Dr. Canter's philosophy is to have coordinated care for the oncology patient.
M.D., University of Pennsylvania School of Medicine, Philadelphia PA 1998
B.A., Princeton University, Princeton NJ 1992
General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1998-2005
Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007
American Board of Surgery, 2006
American College of Surgeons
American Society of Clinical Oncology
Association of Academic Surgeons
Connective Tissue Oncology Society
Pacific Coast Surgical Association
Society for Surgical Oncology
Honors and Awards
Christine and Helen Landgraf Award, UC Davis Comprehensive Cancer Center, 2014
Select Recent Publications
Wasif N, Tamurian RM, Christensen S, Do L, Martinez SR, Chen SL, Canter RJ. Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol. 2012 Feb;19(2):504-10. Epub 2011 Jul 16.
Tseng WH, Martinez SR, Do L, Tamurian RM, Borys D, Canter RJ. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res. 2011 Jun 15;168(2):e173-80. Epub 2011 Mar 6.
Tseng WH, Martinez SR, Tamurian RM, Chen SL, Bold RJ, Canter RJ. Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol. 2011 Apr;103(5):390-4. doi: 10.1002/jso.21849. Epub 2010 Dec 28.
Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug;254(2):333-8.
Canter RJ, Beal S, Borys D, Martinez SR, Bold RJ, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010 Feb;210(2):191-198.e2. Epub 2009 Dec 4.
Canter RJ, Martinez SR, Tamurian RM, Wilton M, Li CS, Ryu J, Mak W, Monsky WL, Borys D. Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol. 2010 Oct;17(10):2578-84. Epub 2010 Jun 17.
Canter, R.J., L-X. Qin, RG. Maki, M.F. Brennan, M. Ladanyi, S. Singer. A synovial sarcoma specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. Dee 15: 14(24) 8191-7. 2008
Canter, R.J., Qin r.x., Ferrone, C.R, Maki R.G., Singer, S, Brennan, M.F. Why do patients with low grade soft tissue sarcoma die? Ann Surg Oneal, Dee; 15(12):3550-60. 2008
Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG, Perioperative Chemotherapy in Patients Undergoing Pulmonary Resection for Metastatic Soft Tissue Sarcoma of the Extremity: A Retrospective Analysis. Cancer. 2007 Nov 1;110(9):2050-60.